Printer Friendly

CNS, INC., REPORTS BREATHE RIGHT(TM)

 MINNEAPOLIS, June 25 /PRNewswire/ -- CNS, Inc. (NASDAQ: CNXS) today announced that it has received a request for additional information from the FDA regarding the company's 510(k) pre-market notification submission on its Breathe Right external nasal dilator.
 The information requested by the FDA deals primarily with the analysis of the company's clinical studies. The company has filed what it believes to be a satisfactory response to the FDA's questions. While it is difficult to predict the timeframe for FDA action, the company hopes to receive a favorable response in the next three to six months.
 CNS, Inc., designs, manufactures and markets medical devices used principally in the diagnosis and treatment of sleep disorders.
 -0- 6/25/93
 /CONTACT: Daniel E. Cohen, M.D., chief executive officer of CNS, Inc., 612-474-7600/
 (CNXS)


CO: CNS, Inc. ST: Minnesota IN: MTC SU:

DS -- MN012 -- 5387 06/25/93 15:53 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 25, 1993
Words:148
Previous Article:DMX(R) GIVEN REGULATORY APPROVAL TO LAUNCH IN CANADA
Next Article:MARQUETTE BANKS MAKES LOW-INTEREST LOANS AVAILABLE TO FLOOD VICTIMS
Topics:


Related Articles
CNS ENTERS INTO A LICENSE AGREEMENT WITH CREATIVE INTEGRATION AND DESIGN; ANNOUNCES NEW PRESIDENT
CNS, INC. GETS APPROVAL TO MARKET NASAL DILATOR
CNS, INC. REPORTS THIRD QUARTER RESULTS
CNS, INC. TO FILE REGISTRATION STATEMENT
CNS, INC. TO OFFER COMMON STOCK
CNS, INC. SELLS COMMON STOCK AND IS APPROVED FOR QUOTATION ON THE NASDAQ NATIONAL MARKET
CNS, INC. REPORTS FIRST QUARTER RESULTS
CNS, INC. ANNOUNCES SALE OF OVER-ALLOTMENT SHARES
CNS, INC. REPORTS DISCUSSIONS FOR PRODUCT ENDORSEMENT
CNS SETTLES LAWSUIT AGAINST BOLLINGER INDUSTRIES, INC.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters